Filing Details

Accession Number:
0001213900-16-012633
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-04-18 17:26:56
Reporting Period:
2016-04-14
Filing Date:
2016-04-18
Accepted Time:
2016-04-18 17:26:56
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1388320 Actinium Pharmaceuticals Inc. ATNM Pharmaceutical Preparations (2834) 880378336
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1566175 Sandesh Seth C/O Actinium Pharmaceuticals, Inc
275 Madison Avenue, 7Th Floor
New York NY 10016
Yes No No Yes
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-04-14 5,000 $2.00 15,000 No 4 P Direct
Common Stock Acquisiton 2016-04-15 2,000 $2.00 17,000 No 4 P Direct
Common Stock Acquisiton 2016-04-15 1,500 $2.01 18,500 No 4 P Direct
Common Stock Acquisiton 2016-04-18 5,000 $1.98 23,500 No 4 P Direct
Common Stock Acquisiton 2016-04-18 1,500 $1.99 25,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Options to purchase common stock Acquisiton 2016-04-15 500,000 $1.99 500,000 $1.99
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
500,000 2026-04-15 No 4 A Direct
Footnotes
  1. Pursuant to the terms of the company's Amended and Restated 2013 Stock Plan, 2% of the options shall vest each month from the date of grant.